GeneDx Holdings Corp. (WGS) Q4 Earnings and Revenues Surpass Estimates
Portfolio Pulse from
GeneDx Holdings Corp. (WGS) reported Q4 earnings of $0.70 per share, surpassing the Zacks Consensus Estimate of $0.20. This marks a significant improvement from a loss of $0.59 per share a year ago.
February 18, 2025 | 1:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GeneDx Holdings Corp. (WGS) reported impressive Q4 earnings of $0.70 per share, significantly beating the Zacks Consensus Estimate of $0.20. This is a notable turnaround from a loss of $0.59 per share a year ago.
The significant earnings beat and turnaround from a loss to a profit is likely to positively impact WGS's stock price in the short term. Investors often react favorably to such earnings surprises.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100